LIFUS-Driven Engineered Bacteria Reprogram Immunosuppressive Niches via Mechano-NOTCH Signaling
Preprint
- 26 May 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
The tumor microenvironment (TME) of solid tumors constructs a complex biophysical barrier with intricate interactions, including dense stromal structures and immunosuppressive networks, which severely limit the permeability and efficacy of immunotherapy. This study developed an engineered an attenuated Salmonella typhimurium VNP20009 strain encoding an acoustic reporter gene (ARG)-based gas vesicles (GVs), enabling real-time tumor imaging guided mechano-immunomodulation. Low-intensity focused ultrasound (LIFUS) triggered cavitation effects from GVs, generating localized shear forces and mechanical strain. This significantly inhibited tumor growth and attenuated the NOTCH-mediated crosstalk between cancer-associated fibroblasts (CAFs) and CD8⁺ T cells, thereby relieving CD8⁺ T cell activity. This mechanobiological intervention elicited a 12-fold enhancement in cytotoxic CD8⁺ T cell infiltration and extended median survival to over 60 days (versus 30-40 days in controls) in aggressive murine tumor models, demonstrating significant therapeutic efficacy. This integrated strategy establishes a closed-loop therapeutic platform combining bacterial targeting, acoustic visualization, and LIFUS-driven mechano-immunomodulation, achieving 92.7% suppression of both primary and metastatic tumor growth. By synergizing synthetic biology with mechano-immunological regulation, our study pioneers a precisely controllable and real-time image-monitored therapeutic paradigm, providing a transformative approach to overcome solid tumor resistance and accelerate clinical translation.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunityBioactive Materials, 2024
- In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic TropismSmall, 2023
- Neutrophil‐Mediated Tumor‐Targeting Delivery System of Oncolytic Bacteria Combined with ICB for Melanoma Lung Metastasis TherapyAdvanced Science, 2023
- The evolving tumor microenvironment: From cancer initiation to metastatic outgrowthCancer Cell, 2023
- Recent advances in bacterial therapeutics based on sense and responseActa Pharmaceutica Sinica B, 2022
- Bacterially mediated drug delivery and therapeutics: Strategies and advancementsAdvanced Drug Delivery Reviews, 2022
- Safety of focused ultrasound neuromodulation in humans with temporal lobe epilepsyBrain Stimulation, 2021
- Engineering CAR-T Cells for Next-Generation Cancer TherapyCancer Cell, 2020
- Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapyCancer Letters, 2019
- Notch Signaling in the Tumor MicroenvironmentCancer Cell, 2018